Healthcare / Healthcare PlansNYSE
$91.03
+0.05 (+0.05%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 22% · confianza 25%
FCF escenarios
weak_data · normalized FCF $7.8B · quality 65.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
48/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$116.1B
P/E
39.9x
↑EV/EBITDA
19.0x
↑ROE
2.4%
↑Gross Margin
13.8%
↓Debt/Equity
1.06
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2007–2025 · 18 años de histórico normalizado
Revenue CAGR
+9.7%
FCF CAGR
+9.9%
FCF margin
1.9%
FCF / Net income
4.42x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $402.07B · net income $1.77B · FCF $7.81B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||||
| Revenue | $402.07B | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | $193.92B | $184.76B | $177.53B | $153.29B | $139.37B | $126.76B | $123.12B | $107.08B | $95.78B | $98.22B | $87.47B | $76.33B |
| Net Income | $1.77B | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | $-594.0M | $6.62B | $5.32B | $5.24B | $4.64B | $4.59B | $3.86B | $3.46B | $3.43B | $3.70B | $3.20B | $2.64B |
| EBITDA | $9.86B | $9.86B | $13.70B | $18.20B | $12.35B | $17.80B | $18.35B | $16.36B | $6.74B | $12.02B | $12.86B | $11.57B | $10.73B | $9.91B | $8.96B | $7.90B | $7.61B | $7.81B | $7.32B | $5.89B |
| EPS | 1.39 | 1.39 | 3.66 | 6.47 | 3.26 | 6.02 | 5.46 | 5.08 | -0.57 | 6.44 | 4.90 | 4.63 | 3.96 | 3.74 | 3.02 | 2.57 | 2.49 | 2.55 | 2.18 | 1.92 |
| Gross Margin | 13.8% | 13.8% | 13.8% | 15.2% | 16.9% | — | — | — | — | 15.4% | 16.3% | 17.3% | 18.2% | 18.8% | 18.3% | 19.2% | 21.1% | 20.7% | 20.9% | 21.1% |
| Operating Margin | 2.6% | 2.6% | 2.6% | 4.1% | 5.1% | 4.6% | 5.2% | 4.7% | 2.1% | 5.2% | 5.9% | 6.2% | 6.3% | 6.3% | 5.9% | 5.9% | 6.4% | 6.5% | 6.9% | 6.3% |
| Net Margin | 0.4% | 0.4% | 1.2% | 2.3% | 1.3% | 2.7% | 2.7% | 2.6% | -0.3% | 3.6% | 3.0% | 3.4% | 3.3% | 3.6% | 3.1% | 3.2% | 3.6% | 3.8% | 3.7% | 3.5% |
| Balance Sheet | ||||||||||||||||||||
| Debt/Equity | 1.06 | 1.06 | 1.10 | 1.04 | 0.99 | — | — | — | 1.23 | 0.59 | 0.70 | 0.71 | 0.31 | 0.34 | 0.24 | — | 0.23 | 0.24 | 0.23 | — |
| Current Ratio | 0.87 | 0.87 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||||
| Free Cash Flow | $7.81B | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B | $13.43B | $10.39B | $6.83B | $6.09B | $7.92B | $6.17B | $6.00B | $3.80B | $4.64B | $3.98B | $2.77B | $1.49B | $1.77B | $1.43B |
| Returns | ||||||||||||||||||||
| ROE | 2.4% | 2.4% | 6.1% | 10.9% | 6.0% | 10.7% | 10.3% | 10.4% | -1.0% | 17.6% | 14.4% | 14.1% | 12.2% | 12.1% | 10.3% | — | 9.1% | 10.3% | 9.2% | 8.4% |
| Valuation | ||||||||||||||||||||
| P/E | 39.93 | 39.93 | 12.51 | 12.58 | 28.10 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 18.98 | 18.98 | 9.64 | 9.68 | 14.50 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 1.54 | 1.54 | 0.76 | 1.37 | 1.70 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||||
| Revenue Growth | 7.8% | 7.8% | 4.2% | 10.9% | — | 8.7% | 4.6% | 32.4% | 5.0% | 4.1% | 15.8% | 10.0% | 9.9% | 3.0% | 15.0% | 11.8% | -2.5% | 12.3% | 14.6% | — |
| EPS Growth | -62.0% | -62.0% | -43.4% | 98.5% | — | 10.3% | 7.5% | 991.2% | -108.9% | 31.4% | 5.8% | 16.9% | 5.9% | 23.8% | 17.5% | 3.2% | -2.4% | 17.0% | 13.5% | — |
| Dividend Yield | 2.9% | 2.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
79.8%
EPS terminal req.
$8.08
Spread vs growth
-141.8%
5Y implied EPS CAGR
47.7%
EPS terminal req.
$9.77
Spread vs growth
-109.7%
10Y implied EPS CAGR
27.5%
EPS terminal req.
$15.74
Spread vs growth
-89.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+45.1%
Start / end P/E
17.5x → 65.5x
EPS bridge
3.66 → 1.39
Residual
-170.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.